PRODUCT INFORMATION
Description
CGGRGD TFA (Cys-Gly-Gly-Arg-Gly-Asp) is a cysteine-terminated hexapeptide featuring the tripeptide Arg-Gly-Asp (RGD) motif. This sequence serves as an integrin-binding domain that mediates cellular adhesion in vitro via interactions with αvβ3/αvβ5 integrin receptors. This synthetic peptide combines RGD's ECM-recognition functionality with an N-terminal cysteine for easy conjugation.
Molecular Weight
677.61
Purity
> 95%
Formula
C₂₁H₃₄F₃N₉O₁₁S
Product Type
Targeting Peptide
Sequence
Cys-Gly-Gly-Arg-Gly-Asp
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- P160 Targeting Peptide (CAT#: OLY-1025-YS-21)
- rTAT Targeting Peptide (CAT#: OLY-1025-YS-20)
- Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
- Cyclic(YCDGFYACYMDV) Targeting Peptide (CAT#: OLY-1025-YS-6)
- Pep2 Targeting Peptide (CAT#: OLY-1025-YS-41)
- IRGD Peptide 1 TFA (CAT#: OLY-1025-YS-58)
- FFAGLDD Targeting Peptide (CAT#: OLY-1025-YS-43)
- Octreotide Pamoate Targeting Peptide (CAT#: OLY-1025-YS-4)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.